The Top (and Only) TSX Cannabis Stock Investors Should Consider Today!

Choose a path

The Canadian cannabis sector has roared higher in recent weeks. Expectations about potential legalization in the U.S. have driven valuations in this sector to fresh 52-week highs recently.

Investors need to be wary of this rapid sector-wide increase. Indeed, picking and choosing specific cannabis stocks is the only way to go. Accordingly, I’d recommend investors should consider Curaleaf (TSXV:CURA) as the only TSX-listed cannabis company to consider right now.

Yes, cannabis could be legalized in the U.S. No, you shouldn’t buy every Canadian cannabis producer on this news.

I think a clear line in the sand needs to be drawn by investors with respect to Canadian cannabis producers right now. Specifically, I think this line should divide companies with significant U.S. exposure and those seeking to gain a foothold south of the border.

The cost of entry into the U.S. market will not be cheap. For Canadian cannabis players looking to acquire their way into America, we could see some crazy premiums paid for market access. The insane levels of overpaying for acquisitions in 2018 could repeat once again. Companies could once again throw caution to the wind and pay whatever price is demanded to get a piece of the action.

The balance sheets of many small Canadian cannabis companies have been effectively destroyed because of imprudent acquisitions already. Accordingly, I’m not sold on the ability of small Canadian producers to succeed in the U.S. market without paying a hefty price.

Focus on companies with U.S. exposure

Right now, Curaleaf is the only Canadian cannabis player with a significant existing presence in the U.S. Yes, other Canadian cannabis companies have partnerships or plans to expand in the U.S. That said, Curaleaf has managed to rollout a U.S.-focused business, and has done so extremely well. I don’t know if the same will ultimately be said about the company’s peers.

This is a company with a massive head start on its Canadian peers. Curaleaf has a completely vertically integrated business model, unlike many of its peers. Upstream, Curaleaf produces its own cannabis and has processing facilities in 23 states. Mid-stream, this is a company with excellent value-added operations. Curaleaf produces a range of oils, vapes, and other value-added products with significantly higher margins than the cannabis commodity itself. Downstream, Curaleaf has almost 100 dispensaries all over the U.S.

Bottom line

This is a company with a realistic trajectory to achieve profitability in the near-term. This is also a company with an excellent growth profile in the U.S. and a historical track record south of the border. Curaleaf has the potential to grow this business organically, and build on its existing expertise to do so. I think the company’s Canadian peers will have a much more difficult time accomplishing this task.

Hands-down, Curaleaf is the only Canadian cannabis company right now I think is worth a speculative bet. For those so inclined to bet on this red-hot sector, I’d recommend considering Curaleaf as the top candidate for consideration right now.

Like this top cannabis pick? Here are some other companies with similar sky-high growth potential!

The 10 Best Stocks to Buy This Month

Renowned Canadian investor Iain Butler just named 10 stocks for Canadians to buy TODAY. So if you’re tired of reading about other people getting rich in the stock market, this might be a good day for you.
Because Motley Fool Canada is offering a full 65% off the list price of their top stock-picking service, plus a complete membership fee back guarantee on what you pay for the service. Simply click here to discover how you can take advantage of this.

Click Here to Learn More Today!

More reading

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

The post The Top (and Only) TSX Cannabis Stock Investors Should Consider Today! appeared first on The Motley Fool Canada.

Source: The Fool
The Top (and Only) TSX Cannabis Stock Investors Should Consider Today!
The Fool

The Motley Fool
Contributor at
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News